13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q2 2016. See the latest, Q2 2026 →
Reported value
$732.58B
+1.4% on the quarter before
Positions
2,647
170 new · 179 sold out
Top 10
14.2%
of the value
Est. gain
+$9.07B
on stocks held all quarter
Est. return
+1.4%
on those stocks since Q1 2016
Positions as of Jun 30, 2016, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 24% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2016. Striped tiles are options.
Largest buys
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Activision Blizzard Inc~$1.96BAdded · 0.3% → 0.6%+49,511,148 shares
- Charter Communications Inc N~$1.96BNew · 0.0% → 0.3%+8,564,964 shares
- S&P Global Inc~$1.79BNew · 0.0% → 0.2%+16,698,423 shares
- Tesla~$927.8MAdded · 0.5% → 0.6%+4,370,600 shares
- Conocophillips~$688.6MAdded · 0.1% → 0.2%+15,793,307 shares
- Vertex Pharmaceuticals Inc~$610.1MAdded · 0.2% → 0.3%+7,092,351 shares
- American Tower~$528.8MAdded · 0.2% → 0.3%+4,654,269 shares
- Lam Research~$519.7MAdded · 0.0% → 0.1%+6,182,540 shares
- Monsanto Co New~$501.7MAdded · 0.1% → 0.2%+4,851,499 shares
- Caterpillar Inc Del~$497.1MAdded · 0.0% → 0.1%+6,557,618 shares
Largest sells
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Mcgraw Hill Finl Inc~$1.76BSold out · 0.2% → 0.0%−17,801,560 shares
- Microsoft~$1.51BCut · 1.2% → 0.9%−29,542,872 shares
- Charter Communications Inc D~$1.44BSold out · 0.2% → 0.0%−7,104,270 shares
- Johnson & Johnson~$1.05BCut · 0.8% → 0.7%−8,656,507 shares
- Apple~$881.1MCut · 2.2% → 1.8%−9,216,735 shares
- General Electric Co~$849.6MCut · 0.8% → 0.6%−26,988,100 shares
- Walt Disney Company (The)~$766.2MCut · 0.6% → 0.5%−7,832,794 shares
- Coca Cola Co~$745.5MCut · 0.7% → 0.6%−16,447,130 shares
- Abbvie Inc~$703.2MCut · 0.2% → 0.1%−11,464,820 shares
- Jpmorgan Chase & Co~$625.3MCut · 0.8% → 0.7%−10,062,841 shares
Holdings
As of Jun 30, 2016. Changes are in shares against Mar 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MetaCL A · shares −3.0% · price +0.2% | 2.3% | $16.90B | +$26.6M | ||||||||
| AmazonCOM · shares −1.1% · price +20.5% | 1.9% | $14.00B | +$2.39B | ||||||||
| AppleCOM · shares −6.3% · price −12.3% | 1.8% | $13.00B | −$1.82B | ||||||||
| AlphabetCAP STK CL A · shares −0.7% · price −7.8% | 1.8% | $12.98B | −$1.10B | ||||||||
| AlphabetCAP STK CL C · shares −2.5% · price −7.1% | 1.5% | $10.72B | −$818.4M | ||||||||
| SalesforceCOM · shares −0.7% · price +7.6% | 1.1% | $7.90B | +$555.3M | ||||||||
| Visa Inc.COM CL A · shares −1.8% · price −3.0% | 1.1% | $7.84B | −$244.3M | ||||||||
| Unitedhealth Group IncCOM · shares −3.5% · price +9.5% | 1.0% | $7.63B | +$664.7M | ||||||||
| Medtronic PlcSHS · shares +0.3% · price +15.7% | 0.90% | $6.60B | +$891.9M | ||||||||
| MicrosoftCOM · shares −19% · price −7.4% | 0.90% | $6.56B | −$520.3M | ||||||||
| Berkshire Hathaway Inc DelCL A · shares 0% · price +1.7% | 0.86% | $6.34B | +$102.9M | ||||||||
| Gilead Sciences IncCOM · shares +2.5% · price −9.2% | 0.80% | $5.83B | −$575.4M | ||||||||
| Wells Fargo & Co NewCOM · shares −3.2% · price −2.1% | 0.79% | $5.77B | −$125.5M | ||||||||
| Johnson & JohnsonCOM · shares −17% · price +12.1% | 0.72% | $5.27B | +$569.0M | ||||||||
| Home Depot IncCOM · shares +2.3% · price −4.3% | 0.72% | $5.25B | −$230.5M | ||||||||
| Chevron Corp NewCOM · shares +0.5% · price +9.9% | 0.71% | $5.23B | +$468.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares −11% · price +4.9% | 0.71% | $5.19B | +$243.7M | ||||||||
| Starbucks CorpCOM · shares −6.1% · price −4.3% | 0.71% | $5.18B | −$233.9M | ||||||||
| Amgen IncCOM · shares +4.0% · price +1.5% | 0.67% | $4.93B | +$69.1M | ||||||||
| General Electric CoCOM · shares −15% · price −1.0% | 0.64% | $4.71B | −$46.4M | ||||||||
| TeslaCOM · shares +27% · price −7.6% | 0.60% | $4.40B | −$286.3M | ||||||||
| MastercardCL A · shares −7.4% · price −6.8% | 0.60% | $4.37B | −$319.4M | ||||||||
| Cvs Health CorpCOM · shares −9.7% · price −7.7% | 0.58% | $4.22B | −$352.4M | ||||||||
| Boston Scientific CorpCOM · shares −5.1% · price +24.2% | 0.57% | $4.19B | +$818.5M | ||||||||
| Bristol Myers Squibb CoCOM · shares −2.7% · price +15.1% | 0.57% | $4.18B | +$549.3M | ||||||||
| Total · 2,647 positions | 100% | $732.58B | +$9.07B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2016 to Q2 2016: 2,423 stocks held throughout, up $9.07B (+1.4%).
- Amazon+$2.39B+21%
- Nvidia+$911.8M+32%
- Medtronic Plc+$891.9M+16%
- Boston Scientific Corp+$818.5M+24%
- Unitedhealth Group Inc+$664.7M+10%
- Microsoft−$520.3M−7%
- Gilead Sciences Inc−$575.4M−9%
- Alphabet−$818.4M−7%
- Alphabet−$1.10B−8%
- Apple−$1.82B−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |